These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17383509)

  • 41. Botulinum toxin for periorbital hidrocystomas in a referral center in Mexico City.
    Schiappapietra-Gerez JM; Santiago-Rea N; Tovilla-Canales JL; Gonzalez-Mondragón E; Nava-Castañeda A
    J Fr Ophtalmol; 2024 Jun; 47(6):104134. PubMed ID: 38453521
    [No Abstract]   [Full Text] [Related]  

  • 42. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
    Hantash BM; Gladstone HB
    Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
    Bowler PJ
    J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
    Balikian RV; Zimbler MS
    Otolaryngol Clin North Am; 2007 Apr; 40(2):291-303. PubMed ID: 17383509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
    Balikian RV; Zimbler MS
    Facial Plast Surg Clin North Am; 2005 Nov; 13(4):583-90, vii. PubMed ID: 16253845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on perioral cosmetic enhancement.
    Suryadevara AC
    Curr Opin Otolaryngol Head Neck Surg; 2008 Aug; 16(4):347-51. PubMed ID: 18626254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient-reported outcomes with botulinum neurotoxin type A.
    Carruthers A; Carruthers J
    J Cosmet Laser Ther; 2007; 9 Suppl 1():32-7. PubMed ID: 17885884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of botulinum toxin A in perioral rejuvenation.
    Kaplan SE; Sherris DA; Gassner HG; Friedman O
    Facial Plast Surg Clin North Am; 2007 Nov; 15(4):415-21, v-vi. PubMed ID: 18005882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum neurotoxins: fundamentals for the facial plastic surgeon.
    Adelson RT
    Am J Otolaryngol; 2007; 28(4):260-6. PubMed ID: 17606044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Facial anatomy and botulinum toxin: the muscular balances].
    Trevidic P; Cauchois R; Ingallina F
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S61-6. PubMed ID: 19576487
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.